palmidrol has been researched along with Arthritis, Degenerative in 5 studies
palmidrol: a cannabinoid receptor-inactive eCB-related molecule used as prophylactic in helping to prevent respiratory viral infection
palmitoyl ethanolamide : An N-(long-chain-acyl)ethanolamine that is the ethanolamide of palmitic (hexadecanoic) acid.
| Excerpt | Relevance | Reference |
|---|---|---|
| ", PEA co-ultramicronized with the natural antioxidant quercetin (PEA-Q), administered orally in two different rat models of inflammatory and OA pain, namely carrageenan paw oedema and sodium monoiodoacetate (MIA)-induced OA." | 7.85 | A novel composite formulation of palmitoylethanolamide and quercetin decreases inflammation and relieves pain in inflammatory and osteoarthritic pain models. ( Britti, D; Crupi, R; Cuzzocrea, S; Di Paola, R; Evangelista, M; Fusco, R; Gugliandolo, E; Impellizzeri, D; Morittu, VM; Schievano, C, 2017) |
| "To carry out a randomized clinical trial to compare the effect of palmitoylethanolamide (PEA) versus ibuprofen, a nonsteroidal anti-inflammatory drug (NSAID), for pain relief in temporomandibular joint (TMJ) osteoarthritis or arthralgia." | 5.16 | Palmitoylethanolamide versus a nonsteroidal anti-inflammatory drug in the treatment of temporomandibular joint inflammatory pain. ( Bartolucci, ML; Bonetti, GA; Bortolotti, F; Gatto, MR; Marini, I, 2012) |
| ", PEA co-ultramicronized with the natural antioxidant quercetin (PEA-Q), administered orally in two different rat models of inflammatory and OA pain, namely carrageenan paw oedema and sodium monoiodoacetate (MIA)-induced OA." | 3.85 | A novel composite formulation of palmitoylethanolamide and quercetin decreases inflammation and relieves pain in inflammatory and osteoarthritic pain models. ( Britti, D; Crupi, R; Cuzzocrea, S; Di Paola, R; Evangelista, M; Fusco, R; Gugliandolo, E; Impellizzeri, D; Morittu, VM; Schievano, C, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jung, JI | 1 |
| Lee, HS | 1 |
| Jeon, YE | 1 |
| Kim, SM | 1 |
| Hong, SH | 1 |
| Moon, JM | 1 |
| Lim, CY | 1 |
| Kim, YH | 1 |
| Kim, EJ | 1 |
| Britti, D | 1 |
| Crupi, R | 1 |
| Impellizzeri, D | 1 |
| Gugliandolo, E | 1 |
| Fusco, R | 1 |
| Schievano, C | 1 |
| Morittu, VM | 1 |
| Evangelista, M | 1 |
| Di Paola, R | 1 |
| Cuzzocrea, S | 1 |
| Alsalem, M | 1 |
| Haddad, M | 1 |
| Aldossary, SA | 1 |
| Kalbouneh, H | 1 |
| Altarifi, A | 1 |
| Jaffal, SM | 1 |
| Abbas, MA | 1 |
| Aldaoud, N | 1 |
| El-Salem, K | 1 |
| Zhou, P | 1 |
| Xiang, L | 1 |
| Yang, Y | 1 |
| Wu, Y | 1 |
| Hu, T | 1 |
| Liu, X | 1 |
| Lin, F | 1 |
| Xiu, Y | 1 |
| Wu, K | 1 |
| Lu, C | 1 |
| Ren, J | 1 |
| Qiu, Y | 1 |
| Li, Y | 1 |
| Marini, I | 1 |
| Bartolucci, ML | 1 |
| Bortolotti, F | 1 |
| Gatto, MR | 1 |
| Bonetti, GA | 1 |
1 trial available for palmidrol and Arthritis, Degenerative
| Article | Year |
|---|---|
Palmitoylethanolamide versus a nonsteroidal anti-inflammatory drug in the treatment of temporomandibular joint inflammatory pain.
Topics: Adult; Amides; Anti-Inflammatory Agents, Non-Steroidal; Arthralgia; Double-Blind Method; Endocannabi | 2012 |
4 other studies available for palmidrol and Arthritis, Degenerative
| Article | Year |
|---|---|
Anti-inflammatory activity of palmitoylethanolamide ameliorates osteoarthritis induced by monosodium iodoacetate in Sprague-Dawley rats.
Topics: Administration, Oral; Amides; Animals; Anti-Inflammatory Agents; Arthritis, Experimental; Dose-Respo | 2021 |
A novel composite formulation of palmitoylethanolamide and quercetin decreases inflammation and relieves pain in inflammatory and osteoarthritic pain models.
Topics: Administration, Oral; Amides; Animals; Anti-Inflammatory Agents; Carrageenan; Drug Combinations; Ede | 2017 |
Role of cannabinoid receptor 1 and the peroxisome proliferator-activated receptor α in mediating anti-nociceptive effects of synthetic cannabinoids and a cannabinoid-like compound.
Topics: Amides; Analgesics; Animals; Cannabinoids; Dronabinol; Ethanolamines; Iodoacetic Acid; Male; Motor A | 2019 |
N-Acylethanolamine acid amidase (NAAA) inhibitor F215 as a novel therapeutic agent for osteoarthritis.
Topics: Amides; Amidohydrolases; Animals; Anti-Inflammatory Agents; Cartilage; Cells, Cultured; Chondrocytes | 2019 |